BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32175410)

  • 21. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
    Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
    Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
    Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
    Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
    Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
    Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
    Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of lymph node ratio in the prediction of rectal cancer patient survival after preoperative chemoradiotherapy.
    Chen L; Huang X; Song Z
    Int J Clin Exp Pathol; 2018; 11(12):5992-6001. PubMed ID: 31949687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
    Peng J; Ma W; Zhou Z; Gu Y; Lu Z; Zhang R; Pan Z
    J Cancer; 2018; 9(6):1067-1077. PubMed ID: 29581786
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
    Jung W; Kim K; Kim J; Shim SJ
    In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
    Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer.
    Lin J; Peng J; Qdaisat A; Li L; Chen G; Lu Z; Wu X; Gao Y; Zeng Z; Ding P; Pan Z
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2551-2560. PubMed ID: 27613188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
    Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
    BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution.
    Kim MJ; Jeong SY; Park JW; Ryoo SB; Cho SS; Lee KY; Park KJ
    Ann Coloproctol; 2019 Apr; 35(2):83-93. PubMed ID: 31113173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
    Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies.
    Zhang J; Xie X; Wu Z; Hu H; Cai Y; Li J; Ling J; Ding M; Li W; Deng Y
    Clin Colorectal Cancer; 2021 Dec; 20(4):e240-e248. PubMed ID: 34334298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
    Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
    Front Oncol; 2020; 10():1280. PubMed ID: 32974129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.